Advertisement
U.S. Markets open in 3 hrs 56 mins
S&P Futures
5,944.25 +5.50 (+0.09%) Dow Futures
43,480.00 +80.00 (+0.18%) Nasdaq Futures
20,776.25 +8.50 (+0.04%) Russell 2000 Futures
2,332.60 -1.50 (-0.06%) Crude Oil
69.70 +0.31 (+0.45%) Gold
2,628.20 -2.80 (-0.11%)
At close: 04:00PM EST
| Previous Close | 70.98 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 70.98 - 70.98 |
| 52 Week Range | 55.09 - 71.05 |
| Volume | |
| Avg. Volume | 458,235 |
| Market Cap | 3.628B |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.10 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireBoston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
ZacksAxonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
Axonics (AXNX) delivered earnings and revenue surprises of 23.08% and 1.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.